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ABSTRACT
Black body syndrome causes mass mortality in barramundi (Lates calcarifer) in Asia mariculture. This study aimed 
to evaluate the efficacy of bivalent vaccine derived from local isolate for black body syndrome (BBS) prevention 
on the Barramundi. The bacteria used in the bivalent vaccine were Pseudomonas stutzeri and Vibrio harveyi in a 
ratio of 50:50. Barramundi, 5–6 cm in length, was intraperitoneally injected with bivalent vaccine and phosphate 
buffer saline (PBS). After a 21-day vaccination, fish was injected with pathogenic bacteria P. stutzeri, V. harveyi, 
the combination of P. stutzeri and V. harveyi with a dose of bacteria 107 CFU/fish. We observed relative percent 
survival (RPS), mortality, blood profile, antibody level, lysozyme activity, and histopathology of vaccinated fish. 
The result showed that vaccinated fish had higher antibody levels and lysozyme activity than control treatment 
(P>0.05). Vaccinated fish had RPS of 80.00%, 64.29%, 57.69%, after challenged test with P. stutzeri, V. harveyi, 
and combination of P. stutzeri and V. harveyi, respectively. Hemoglobin and hematocrit were not significantly 
different (P>0.05). However, the erythrocytes, leucocytes, and phagocytic activity were higher compared to there 
were higher erythrocytes, leucocytes, and phagocytic activity compared to control (P<0.05). As well as antibody 
level and lysozyme activity of vaccinated fish higher than control (P<0.05). In conclusion, the bivalent vaccine of 
P. stutzeri and V. harveyi could protect barramundi seed from BBS infection. 
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ABSTRAK
Black body syndrome menyebabkan kematian masal pada ikan kakap putih budidaya air laut di wilayah Asia. 
Tujuan dari penelitian ini adalah untuk menguji efikasi vaksin bivalen untuk penanggulangan black body syndrome 
pada benih ikan kakap putih. Bakteri yang digunakan untuk membuat vaksin bivalen yaitu Pseudomonas stutzeri 
dan Vibrio harveyi dengan rasio 50:50. Ikan kakap putih berukuran 5–6 cm diinjeksi vaksin bivalen dan phosphat 
buffer saline secara intraperitoneal. Setelah 21 hari pemeliharaan, benih diuji tantang dengan bakteri patogen 
P. stutzeri, V. harveyi, campuran P. stutzeri dan V. harveyi dengan kepadatan bakteri sebesar 107 CFU/ikan. 
Parameter yang diamati meliputi relative percent survival (RPS), gambaran darah, titer antibodi, aktifitas lisosim, 
dan gambaran histopatologi benih kakap putih. Hasil penelitian menunjukkan bahwa ikan yang divaksin memiliki 
nilai titer antibodi dan aktifitas lisosim lebih tinggi dibandingkan kontrol (P<0.05). Ikan yang divaksin memilki 
RPS 80.00%, 64.29%, 57.69%, setelah diuji tantang dengan P. stutzeri, V. harveyi, campuran P. stutzeri dan V. 
harveyi. Nilai hemoglobin dan hematokrit tidak berbeda nyata (P>0.05). Titer antibodi dan aktifitas lisosim ikan 
yang divaksin lebih tinggi dari kontrol (P<0.05). Vaksin bivalen P. stutzeri dan V. harveyi dapat melindungi benih 
ikan kakap putih dari infeksi BBS.
Kata kunci: Lates calcalifer, vaksin bivalen, Pseudomonas stutzeri, Vibrio harveyi
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INTRODUCTION
Barramundi or Asian seabass is a commercially 
important aquaculture species in south-east Asia 
and Australia. Barramundi is widely distributed 
in marine, freshwater, and brackish coastal 
environment and is a demersal catadromous 
fish. Production of the fish has progressively 
increased in the past years (Siddik et al., 2016; 
Venkatachalam et al., 2018). Other than that, new 
technological advances and increased demands 
for fish as a source of animal protein are the main 
reasons for the industry’s growth. Expansion 
of the industry caused more intensive culture 
methods for producing higher yields (Rico et al., 
2012). Recently the sector attracted great attention 
and it is growing rapidly through the development 
of aquaculture, and intensification in the activity 
of barramundi fish farming increases the risk 
of environmental pollution that can lead to an 
outbreak disease (Dong et al., 2017; Kubecka 
et al., 2016; Sharma et al., 2012; Ransangan & 
Manin, 2010).  Hamed et al. (2018) stated that the 
appearance and development of fish diseases were 
the results of the interactions among pathogens, 
hosts, and the environment.  Deteriorating 
environmental conditions causes new diseases 
popping up and causing huge losses. 
In recent years an emerged disease attacks 
barramundi seed with clinical symptoms such as 
blackening body, passive movement, low appetite, 
bleeding in the lower abdomen, as well as liver, 
kidney, and the spleen of the barramundi seed 
turns pale caused by  P. stutzeri and  V. harveyi 
attack. This is following Ransangan and Saleem 
(2009); Ransangan et al. (2012) stated that 
bacterial infections caused many deaths and high 
losses on the culture of barramundi. The bacterial 
attack is inseparable from bacterial properties they 
have, as an example, the opportunistic bacteria 
such as Vibrionaceae and Pseudomonadaceae, 
a dominant halophilic bacteria, are pathogenic 
bacteria to marine organisms and also human. 
Assefa and Abunna (2018) mentioned that 
the emergence of disease  outbreak could cause 
considerable losses in fish cultivation, thus it 
required effective action and appropriate bacterial 
disease control. The use of antibiotics cannot 
be tolerated because it potentially harm and 
it is not environmentally friendly. Ozturk and 
Altinok (2014); Wali and Balkhi (2016) stated 
that prevention of disease is preferable to disease 
treatment, both infectious and noninfectious 
outbreaks. Beyond that, correct diagnosis and 
environmentally acceptable treatment methods 
should be carried out. Disease prevention using 
fish submersion method in water and liquid 
antiseptic is considered ineffective, so it requires 
other methods to control the disease.
Vaccination is an attempt to produce specific 
antibody, safe and effective that can be used for 
the sustainable development aquaculture industry 
(Evensen & Leong, 2013). In response to reduced 
antibiotic use in fish, production vaccines have 
been playing a key role in infectious disease 
control in aquaculture for decades. Vaccines 
get wide acceptance for the fact there is no risk 
of drug resistance development in vaccinated 
animals (Assefa & Abunna, 2018). BBS caused by 
an infection of various bacteria such as P. stutzeri, 
V. harveyi, Bacillus cereus, and  Salinococcus 
roseus. Based on the five bacteria,  P. 
stutzeri and V. harveyi is the most pathogenic and 
showed clinical symptoms of BBS in the tested 
fish (Izwar, 2018).  Therefore, for controlling 
this disease should be developed a polyvalent 
vaccine, as well as on specifically aimed at testing 
the immunogenicity and protection of vaccinated 
barramundi.
MATERIALS AND METHODS
Time and place
The study was conducted from February 2017 
to August 2017 at the Laboratory of Aquatic 
Organism Health, Department of Aquaculture, 
Faculty Fisheries and Marine Sciences, Bogor 
Agricultural University and the Centre for 
Mariculture Research Development (BBPBL) 
Lampung.
Fish test
Seeds of 5–6 cm barramundi fish obtained 
from the cultivators in the barramundi Kalianda 
area, South Lampung. All the fish were tested by 
examining the outer conditions of fish and internal 
organs of the fish, such as kidneys, liver, and 
crushed spleen then scraped into the agar medium, 
if there were no bacteria then the fish was safe to 
use.  Fish was kept in aquarium size 40×40×60 
cm3 with a density of 1 fish per liter. Barramundi 
seed was adapted to the environmental conditions 
and feed for one week using commercial pellets 
provided at satiation.
Experimental design
This study consisted of the treatment of 
barramundi which was bivalent and vaccinated 
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seeds injected by phosphate buffer saline (PBS) 
as control and treatment of challenge tests with 
single bacteria and bacteria combined.  The 
design of the challenge test treatment is presented 
below in Table 1.
Vaccine making test
The formalin-killed cell (FKC) vaccine from 
each of the bacteria was made by reference from 
Kumaran et al. (2010). The single bacterial vaccine 
with each concentration of 109 CFU/mL was then 
mixed with a 50:50 ratio to get the bivalent 
vaccine P. stutzeri and V. harveyi. Vaccines were 
packed in bottles and stored in cabinets in low 
temperature until used.
Seed vaccination
A total of 200 barramundi seeds were injected 
through intraperitoneal using a 0.1 mL/ind of 
bivalent vaccine, while the control fish group was 
injected with a PBS solution of 0.1 mL/ind. The 
next fish was kept for 21 days.
Challenge test
The seed test was performed on the 22nd day 
after vaccination with pathogenic bacteria P. 
stutzeri, V. harveyi, and the combination of P. 
stutzeri and V. harveyi using 0.1 mL with a 
bacterial density of 107 CFU/mL (corresponding 
to a dose of LD50) of 0.1 mL/ind. The seed was 
reared in an aquarium with a stocking density of 
15 fish/aquarium. Mortality and RPS seeds were 
observed until seven days after the challenge test. 
Parameter of research
The observed parameters were relative percent 
survival (RPS), mortality, blood profile, antibody 
titers, lysozyme activity, and liver histopathology.
Relative percent survival (RPS)
The calculation of RPS value was done at the 
end of the research to determine the effectiveness 
of the applied vaccine. RPS was calculated using 
(1988) formulation:
Table 1. The design of the challenge test on barramundi seed after vaccination
Treatment Information
V1 The seed was vaccinated with bivalent vaccine and challenged with P. stutzeri
V2 The seed was vaccinated with bivalent vaccine and challenged with V. harveyi 
Vg The seed was vaccinated with bivalent vaccine and challenged with mix bacteria P. stutzeri and V. harveyi
Vk The seed was vaccinated with bivalent vaccine and challenged with PBS
K1 The seed was injected with PBS and challenged with P. stutzeri
K2 The seed was injected with PBS and challenged with V. Harveyi
Kg The seed was injected with PBS and challenged with mix bacteria P. stutzeri dan V. harveyi
Kk The seed was injected with PBS and challenged with PBS
Blood view observation
The blood sample was taken from caudal fin 
veins. Observation of blood profile parameters 
consisted of erythrocyte cell counts, leukocyte 
count, hemoglobin, hematocrit, and phagocytic 
activity.  Total erythrocytes and leukocyte were 
calculated using the method of Blaxhall and Daisley 
(1973).  Hemoglobin levels were measured by 
Sahli method (Wedemeyer & Yasutake, 1977). The 
hematocrit was measured using the Anderson and 
Siwicki (1993) methods. Phagocytic activity was 
calculated based on the Anderson and Siwicki (1993) 
methods.
Antibody testing
Testing of antibody titer was performed on a 
96-wells microplate-based on a method referred 
to Takahashi et al. (2014). Measurement of 
antibody titer was performed by taking 25 μL of 
PBS solutions and put into microplate at holes 1 
to 12, then inserted blood serum in the hole 1 as 
much as 25 μL. Series of dilution were performed 
from hole 1 to 11. A 25 μL of bacterins were 
inserted into holes 1 to 12. Furthermore, it was 
stored for two hours in the incubator at 37°C, 
followed by saving it in the 4°C refrigerator for 
24 hours. The antibody titer was determined from 
the last remaining hole an agglutination reaction 
was found.
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Lysozyme activity
The lysozyme activity was measured by the 
method by Ellis (1990).  Lysozyme activity was 
limited to several enzymes that caused a decrease 
in absorbance of 0.001/min. Here is the lysozyme 
calculation formula: 
results showed that the administration of the vaccine 
was effective in maintaining the survival of the 
barramundi infected with high pathogenicity bacteria. 
The profile of barramundi seeds blood after 
vaccination and challenge test
The hematocrit value of day 7 after 
vaccination did not significantly different 
between all treatments (P>0.05). However, there 
were differences in total erythrocytes, leucocytes, 
hemoglobin, and phagocytic activity. Hematocrit 
seeds ranged from 13.10 to 15.91%.  Total 
erythrocytes, leucocytes, hemoglobin, and 
phagocytic activity of barramundi seeds higher 
vaccine treatment compared with control and 
initial treatment (before vaccination) (P<0.05). 
The overview blood profile of barramundi seed 
21 days after vaccination is presented in Table 3. 
The blood profile of barramundi seed at 
seven days post-challenge between groups of 
fish vaccines and fish controls, each of which 
was tested against  P. stutzeri, V. harveyi , the 
combination of P. stutzeri and V. harveyi , as 
well as the controls gave distinctly different 
values (P<0.05) in total erythrocytes, leucocytes, 
and phagocytic activity, whereas in hemoglobin 
values group vaccine fish treatment ranged from 
11.00 to 12.00 g/dL was not significantly different 
(P>0.05) with control group of fish that ranged 
between 10.33‒11.33 g/dL and hematocrit group 
Data analysis
This research used a completely randomized 
design.  All data were tabulated with 
Microsoft  Office  Excel  2013.  The RPS data, 
blood profile, antibody titers, and lysozyme 
activity were analyzed using ANOVA with SPSS 
24.0 at a significant level of 95%. A significant 
result would be analyzed further using a post-hoc 
Duncan›s test. Histopathology data were analyzed 
descriptively.
RESULTS
Mortality rate and  relative percent 
survival (RPS) seed of barramundi
The mortality rate of barramundi seeds injected 
with the bivalent vaccine was significantly greater 
(P<0.05) than control until day 29, so did the value 
of RPS vaccinated fish (P<0.05) compared with the 
control treatment on the 29th day of rearing. These 
Table 2. Mortality rate and RPS of vaccinated barramundi seed
Treatment Challenge test Mortality (%) RPS (%)
Vaccine
P. stutzeri 16.67 ± 3.85a 80.00 ± 3.70b
V. harveyi 33.33 ± 3.84b 64.29 ± 5.10a
Combination 36.67 ± 3.85b 57.69 ± 2.28a
Control
P. stutzeri 83.33 ± 3.85c -
V. harveyi 93.33 ± 3.84cd -
Combination 86.67 ± 6.67d -
Note: Different superscript on the age of seeds and the same parameters show an influence The treatment was 
significantly different (Duncan’s test; P<0.05).
Table 3. Dosage of barramundi seed seven days post-vaccination on seed treatment injected bivalent vaccine (V), 
seed injected PBS (K)
Treatment ∑ Erythrocyte(×106 cell/mm)
∑ Leucocyte
(×104 cell/mm)
Hb 
(g/dL)
Hc 
(%)
AF 
(%)
Initial 3.81 ± 0.00bc 3.15 ± 0.00a 12.00 ± 0.00a 15.10 ± 0.12b 24.00 ± 0.00a
Vaccine 4.09 ± 0.20c 6.31 ± 0.10c 13.67 ± 0.00b 15.89 ± 0.14b 29.00 ± 1.73c
Control 3.62 ± 0.41a 3.43 ± 0.09b 12.67 ± 0.58a 14.99 ± 1.03a 23.00 ± 1.53b
Note: Hemoglobin (Hb), hematocrit (Hc), phagocytic activity (AF), different superscript on the age of the seed and 
the same parameters indicated significant different (Duncan’s P<0.05).
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of fish vaccine with the range of 9.81‒14.29% 
there is no difference (P>0.05) with the control 
fish group in the range of 7.84‒9.78% among 
all treatments. The blood profile barramundi of 
seventh-day post-banding is presented in Table 4.
Antibody titer post-vaccination and challenge 
test of barramundi seed
Giving vaccine in barramundi seed had a 
significant effect (P<0.05) to the titer value of 
barramundi seed antibody during the rearing 
period. The antibody of vaccinated fish increased 
by two to four on day seventh after vaccination 
and significantly higher (P<0.05) than control 
treatment that was not increased. Provision of the 
vaccine in barramundi seed was also influential 
significant to barramundi seed antibodies 
tested challenge with  P. stutzeri bacteria (1), V. 
harveyi (2), a combination of P. stutzeri and V. 
harveyi (g), and PBS (k). The antibody titer of 
each treatment is presented in Figure 1. 
Lysozyme activity of barramundi seed after 
vaccination and challenge test
The lysozyme activity of bivalent vaccinated 
seed was significantly higher on day 7 post 
vaccination compared with control treatment 
(P<0.05).  Vaccine also effected the lysozyme 
activity of barramundi seed after the challenge 
test. Lysozyme activity of vaccinated fish 
which challenge with P. stutzeri bacteria (1), V. 
harveyi (2), combination of P. stutzeri and V. 
harveyi (g), and PBS (k) were significantly 
higher than the control challenge against the same 
bacteria. Lysozyme activity of barramundi seed 
after vaccination is presented in Figure 2.
Histopathological observation
The histopathology result of barramundi 
fish after challenge test showed the presence of 
microscopic anatomical pathology difference 
in both treatment and control experimental 
fish using the combination bivalent vaccine P. 
stutzeri and V. harveyi (Figure 3A & 3B). It 
was noticed in Figure 3A that hepatocytes was 
healthy and normal, whereas in Figure 3B most 
of the hepatocytes experienced necrosis. The 
histology profile of the experimental barramundi 
is presented on Figure 3.
Table 4. Blood profile barramundi seed 7 days post-challenge with the injected bivalent vaccine (V), and injected 
with PBS (K), respectively tested challenge with bacteria P. stutzeri, V. harveyi, combined of P. stutzeri and V. 
harveyi, and control
Treatment Challenge test
∑ Erythrocyte
(×106 cell/mm)
∑ Leucocyte
(×104 cell/mm)
Hb 
(g/dL)
Hc 
(%)
AF 
(%)
Vaccine P. stutzeri 2.62 ± 0.16c 6.35 ± 0.21b 12.00 ± 0.00cd 14.29 ± 0.95d 34.00 ± 1.00c
V. harveyi 2.35 ± 0.28bc 6.80 ± 0.28b 12.00 ± 0.00cd 11.99 ± 0.60c 35.00 ± 1.00c
Combination 2.10 ± 0.16b 6.85 ± 1.20b 11.00 ± 0.00b 9.81 ± 0.71b 38.50 ± 1.53d
Control P. stutzeri 1.48 ± 0.30a 4.55 ± 0.07a 10.33 ± 0.58a 9.78 ± 1.11b 30.50 ± 1.53b
V. harveyi 1.39 ± 0.08a 4.55 ± 0.07a 10.67 ± 0.58ab 7.96 ± 0.06a 29.00 ± 1.00ab
Combination 1.33 ± 0.13a 4.60 ± 0.14a 11.33 ± 0.58bc 7.84 ± 0.42a 29.00 ± 1.00ab
Note: Hemoglobin (Hb), hematocrit (Hc), phagocytic activity (AF). Different superscript on the age of seeds and 
similar parameters indicated significant different treatment effects (Duncan’s test;P<0.05).
Figure 1. A.  Antibody titer of barramundi seed pre-vaccination and seven days post-vaccination using bivalent 
vaccine (V), and injected PBS (K). B. Antibody titer of barramundi seed seven days post-challenge which injected 
using P. stutzeri (1), V. harveyi (2), the combination of P. stutzeri and V. harveyi (g), and control (k). Different 
superscript in each bar indicated the treatment was significantly different (Duncan’s P<0.05).
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DISCUSSION
Vaccination is a prevention method made from 
antigens derived from pathogens and made non-
pathogenic through various ways which stimulates 
the specific immunity to control infectious 
diseases in fish, such as bacteria and virus attacks, 
and has been proven significantly in preventing 
disease outbreaks, and it also has low cost (Roar 
& Muiswinkel, 2013; Wali & Balkhi, 2016; 
Ayalew & Abunna, 2018; Shefat, 2018). Health 
status of vaccinated fish immunity becomes one 
of the prove of fish health status and determine 
the relation with fish immune conditions before 
and after vaccination to demonstrate efficacy and 
extent protection of the vaccine (Tobar  et al., 
2015). Bivalent vaccine can protect barramundi 
with RPS up to 80.00% when challenged with P. 
stutzeri bacteria, 64.29% when challenged with V. 
harveyi, 57.69% when challenged with combined 
bacteria.  Mulia (2007) stated that the vaccine 
was considered to be effective if relative survival 
yields more than 50%. Results research showed 
that applying the bivalent vaccine was effective 
in protecting the barramundi seeds towards 
BBS.  Bivalent vaccination is effective in the 
protection against single or combined bacterial 
infections. It is one of the advantages of using a 
multivalent vaccine. The utilization of one dose 
of vaccine containing many antigens affects 
the effectivity and reduces the stress of the fish 
(Shoemaker et al., 2012).
The low mortality rate and the relatively 
high survival rate of vaccination treatment were 
generally caused by the formation of a non-specific 
immune response followed by specific immune 
enhancement. The specific immune formation 
was indicated by increased levels of antibodies. 
Besides the formation of specific immune as well as 
indicated by the activity of T cells (T helper cells, 
cytotoxic T cells, and T memory cells) and B 
cells (B-cell memory and cell plasma).  The B 
cell memory would store information about the 
antigenic characteristics that enter the body 
while the cell›s plasma would produce a specific 
antibody to the antigen.  Antigens that entered 
Figure 2. Lysozyme activities of barramundi before vaccination (early), as well as on seven days post vaccination 
with bivalent vaccine injection (V) and control treatment the PBS (K) injection (A); Lysozime activity of 
barramundi seed seven days post challenges that were injected by P. stutzeri bacteria (1), V. harveyi (2), P. stutzeri 
and V. harveyi (g), and control (k) (B). Different superscript in each bar indicated the effect of treatment was 
significantly different (Duncan’s P<0.05)
Figure 3. Microscopic anatomical pathology of liver tissue of barramundi on 7th day after a combined bacterial 
infection of P. stutzeri and V. harveyi: A) Liver tissue of barramundi that was vaccinated and challenged test with 
the combined bacteria was normal and still had nucleus with normal hepatopancreas; B) Liver tissue of barramundi 
injected with PBS and challenge tested using combined bacteria experienced necrosis (Nk).
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the body was engulfed by macrophages.  Once 
it was engulfed, the antigen will be exposed 
to the T helper cells through protein  major 
histocompatibility complex (MHC) class II. The 
T helper cells will activate by macrophages 
through cytokine molecules. After being activated 
with cytokines from macrophages, the helper 
will produce cytokines that stimulate B cells, T 
cells memory, and cytotoxic T cells.  When the 
identical antigen exposes for the second time, 
T cell memory will stimulate B cell memory to 
proliferate into cell plasma and produce antibody. 
The nonspecific immune response is indicated 
through the congenital body defense system and 
hematological parameters (Reece et al., 2014).
The blood profile parameters have been used 
as indicators of health status in some species 
(Santos et al., 2009; Adedeji, 2010; Akinrotimi et 
al., 2012; Sayed & Moneeb, 2015).  One of the 
parameters to indicate fish health status is the 
total of erythrocytes.  The value of erythrocytes 
after the challenge test was known to decrease in 
all treatments, especially in the control treatment. 
This was presumably because one of the bacteria 
used in the challenge test (V. harveyi) can break 
red blood cells so that levels of erythrocytes 
tend to decline. Minasyan (2014) stated that 
hemoglobin helps kill bacteria, that happens 
when erythrocytes are lysed by bacteria their 
hemoglobin releases free radicals which break 
down the pathogen’s cell wall and membrane, 
killing it. For hematocrit, Sukenda et al. (2014) 
were reported that the hematocrit on vaccinated 
fish had no significant effect on fish health 
status. However, there was an effect on the total 
leucocytes and phagocytic activity of vaccinated 
fish.  Results of blood profile post-vaccination 
still showed a normal value.  However, the 
health status of barramundi vaccinated using the 
bivalent vaccine was greater than other treatments 
post-vaccination or after the challenge test. The 
result was noticed in the total leucocytes and 
phagocytic activity in vaccinated barramundi 
seed has a significantly higher value compared 
to control treatment. This was suspected because 
the antibody titer of vaccinated treatments was 
significantly higher than the control treatment. 
According to Reece et al. (2014) antibody might 
bind to the antigen on the surface of the bacteria 
cell thus it blocks the site of bacteria recognition 
on its host and facilitates phagocytosis. The 
antibody that binds to the antigens on the surface 
of bacteria cells is also capable of forming 
complexes with protein complements.  These 
protein complements will insert into the bacterial 
cell membrane and form a pore which then lyses 
the cell target. Nonspecific body defense systems, 
such as phagocytic activity and lysozyme activity, 
also play a role in reducing the exposure of P. 
stutzeri and V. harveyi bacteria in the fish body.
The immune response represents the immune 
conditions of the fish, both specific and nonspecific 
immune system. The specific immunity that can 
show the efficacy level of the vaccine is the value 
of the antibody titer. The results showed that the 
administration of the vaccine in barramundi gives 
a significantly effective than unvaccinated seeds. 
The results of antibody titer measurements in two 
groups (vaccine and control) showed that there 
was an increase of antibody titer in the vaccinated 
treatment after vaccination which reached a 
value of 4 compared to the group of fish injected 
with PBS (K) during the rearing period after 
vaccination (day 7) (Figure 1). Raida et al. (2011) 
stated that whole vaccines which put into the fish 
body intraperitoneally increased specific antibody 
compared to unvaccinated fish.  This matter 
showed that vaccination was the potential to induce 
specific antibody responses.  Sun  et al. (2014) 
added that the application of V. harveyi vaccine 
was injected to Parachthys olivaceus seeds, was 
able to support its survival when tested using V. 
harveyi and S. iniae. Comparing with mortality 
data in Table 2, the vaccinated group shows 
the lowest mortality percentages, as well as the 
antibody titers data (Figure 1). This result same 
to Villumsen et al. (2012); Romstad et al. (2013); 
Marana et al. (2017) that stated if antibody titers 
are related to survival rate between unvaccinated 
fish and vaccinated fish. 
Lysozyme is a bacteriolytic enzyme produced 
in lysosomes in phagocyte cells, suggesting that 
lysozyme plays a conserved role in host defense 
across the animal kingdom. Lysozyme works by 
destroying bacterial cells via targeted hydrolysis of 
bacterial cell walls, which are critical for the resistance 
of bacteria to osmotic stress (Callewaert & Michiels, 
2010; Uribe et al., 2011; Ragland & Criss, 2017).  
Lysozyme activity of barramundi seed on the seventh 
day after vaccination between the treatment of bivalent 
vaccines and controls was significantly different 
(P<0.05). The activity of lysozyme seeds injected 
by the bivalent vaccine increased rapidly compared 
with nonvaccinated control. This was indicated by 
a considerable value between vaccine and control 
treatments on day seven after vaccination of (4.69 U/
mL (V) and 2.79 U/mL (K)). A similar thing also 
occurred after the challenge test.  Barramundi’s 
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seed on bivalent vaccine treatment tested 
with P. stutzeri (1), V. harveyi (2), combined P. 
stutzeri and  V. harveyi (g), and the control of 
PBS (k) had higher lysozyme activity compared 
with control treatments that tested against the 
same bacteria.  The activity of lysozyme after 
the highest challenge test is obtained by the 
combined Vg (combined) treatment showed 
that bivalent vaccinated seeds were then tested 
with P. stutzeri and V. harveyi which can induce 
nonspecific immune systems with lysozyme 
values  of 193.79 U/mL.  It was suggested that 
vaccination did not only improve specific 
immune responses but also enhances nonspecific 
immune. The utilization of the bivalent vaccine 
in barramundi’s seed also affected the condition 
of microscopic internal organs. Figure 3A showed 
the liver organ of the bivalent combination vaccine 
had plenty of normal and healthy hepatocyte cells 
at 7th the challenge test, while Figure 3B is the 
treatment of fish seed injected by PBS and tested 
against combined bacteria. Both of them took on 
the same day and of the two there are differences 
with the number of necrotic hepatocyte cells. The 
result of research from El-Sharaby et al. (2018), 
are known that the histopathological examination 
of the livers naturally infected fishes by Vibrio 
showed necrosis of hepatocytes, necrotic means 
the death of cells or tissues caused by diseases. 
Healthy liver cells in Figure 3A showed that 
bivalent vaccines can protect fish from necrotic 
cells and mortality. 
CONCLUSION
Bivalent vaccines were effective in 
controlling BBS disease in terms of the value 
of RPS on all treatments which was more than 
50%. The bivalent vaccine of  P. stutzeri and V. 
harveyi bacteria potentially protected the barramundi 
seed to prevent BBS disease outbreak.
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